Senescence risk score signature

Biomarker

1 paper studies it1 finding

  • In silico1

Associations

1

Mortality

downin silico1

1 study
  1. Senescence risk score signature predicts mortality in silico (HR >1, P<0.001).

    “The high-risk group had a worse prognosis [both hazard ratio (HR) >1, P<0.001]”

    In silicoliver hepatocellular carcinoma

    Construction and validation of senescence risk score signature as a novel biomarker in liver hepatocellular carcinoma: a bioinformatic analysis

    Translational cancer research

Latest